Ardelyx (ARDX) Current Assets (2013 - 2026)
Ardelyx (ARDX) reported Current Assets of $381.9 million for Q1 2026, up 22.12% on a YoY basis from $312.7 million in Q1 2025, and little changed quarter-over-quarter from $382.3 million in Q4 2025.
Ardelyx (ARDX) Current Assets (2013 - 2026) Analysis & Trends
Ardelyx has reported Current Assets for 14 years, with the latest figure at $381.9 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets rose 22.12% year-over-year to $381.9 million; the trailing twelve-month figure through Mar 2026 stood at $381.9 million (up 22.12% YoY), and the FY2025 full-year result was $382.3 million, up 7.26% from the prior year.
- Current Assets for Q1 2026 stood at $381.9 million, roughly flat from $382.3 million in the prior quarter.
- The five-year high for Current Assets was $382.3 million in Q4 2025, with the low at $114.1 million in Q2 2022.
- Historically, Current Assets has averaged $251.5 million across 5 years, with a median of $257.9 million in 2024.
- Annual changes were most pronounced in 2022 — Current Assets sank 44.38% — and 2023, when it jumped 101.22%.
- Ardelyx's Current Assets stood at $153.6 million in 2022, then soared by 60.23% to $246.1 million in 2023, then soared by 44.83% to $356.5 million in 2024, then increased by 7.26% to $382.3 million in 2025, then retreated by 0.12% to $381.9 million in 2026.
- The last three Current Assets figures came in at $381.9 million (Q1 2026), $382.3 million (Q4 2025), and $368.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 381.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 381.87 Mn |
| Dec 31, 2025 | 382.32 Mn |
| Sep 30, 2025 | 367.99 Mn |
| Jun 30, 2025 | 351.57 Mn |
| Mar 31, 2025 | 312.69 Mn |
| Dec 31, 2024 | 356.45 Mn |
| Sep 30, 2024 | 284.10 Mn |
| Jun 30, 2024 | 263.02 Mn |
| Mar 31, 2024 | 257.94 Mn |
| Dec 31, 2023 | 246.11 Mn |
| Sep 30, 2023 | 241.22 Mn |
| Jun 30, 2023 | 162.12 Mn |
| Mar 31, 2023 | 167.05 Mn |
| Dec 31, 2022 | 153.60 Mn |
| Sep 30, 2022 | 119.88 Mn |
| Jun 30, 2022 | 114.11 Mn |
| Mar 31, 2022 | 114.23 Mn |
| Dec 31, 2021 | 133.65 Mn |
| Sep 30, 2021 | 153.38 Mn |
| Jun 30, 2021 | 186.49 Mn |